Publications by authors named "E G Solomou"
This is a case report of a 54-year-old patient with hepatocellular cancer under palliative chemotherapy who admitted with dyspnea on minimal exertion and peripheral oedema over the past 5 days. Echocardiogram revealed a large echogenic mass in the right atrial cavity which did not enhance with intravenous echo contrast agent, and a distended inferior vena cava (IVC) which was occluded by echogenic material with no signs of flow. To distinguish with accuracy if the thrombus was a bland or tumor thrombus, contrast-enhanced Computed Tomography (CT) was performed.
View Article and Find Full Text PDF: The widespread use of fluoroquinolones has been associated with the formation, dissection, and rupture of aortic aneurysms. Arterial biomarkers are established predictors of cardiovascular events. The present study was designed to investigate the effect of quinolones on arterial stiffness and aortic size for the first time.
View Article and Find Full Text PDFArticle Synopsis
- - Defective telomerase function leads to genomic instability, resulting in telomere biology disorders (telomeropathies), which are characterized by variations in telomere length and related health issues.
- - These disorders can cause multiple organ effects and exhibit a variety of symptoms even among family members, sometimes linking to previously unexplained diseases like pulmonary fibrosis and liver cirrhosis.
- - Patients with telomere biology disorders have an increased risk of specific cancers and may experience heightened sensitivity to standard chemotherapy, highlighting the need for better awareness and a multidisciplinary management approach for these conditions.
Chronic lymphocytic leukemia (CLL) is characterized by disease- and treatment-related immunosuppression. Patients with CLL comprise a vulnerable population to coronavirus disease 2019 (COVID-19), while the protective effect of COVID-19 vaccination remains uncertain.We conducted a systematic review to evaluate published data reporting response to COVID-19 vaccination in patients with CLL.
View Article and Find Full Text PDF